Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents
IJC Heart & Vessels · 2014-06 · 3 · 68-74
DOI: 10.1016/j.ijchv.2014.03.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift IJC Heart & Vessels, 2014-06. Verfasst von Kadriye Kilickesmez und 14 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
AIMS: Characterization of neointimal tissue is essential to understand the pathophysiology of in-stent restenosis (ISR) after drug eluting stent (DES) implantation. Using optical coherence tomography (OCT), we compared the morphologic characteristics of ISR between first and second generation DES. METHODS AND RESULTS: OCT was performed in 66 DES-ISR, defined as > 50% angiographic diameter stenosis within the stented segment. Patients with ISR of first generation sirolimus-eluting stents (SES), paclitaxel eluting stents (PES) and second generation zotarolimus-eluting stents (ZES), everolimus-eluting stents (EES) and biolimus-eluting stents (BES) were enrolled. Quantitative and qualitative ISR tissue analysis was performed at 1-mm intervals along the entire stent, and categorised as homogeneous, heterogeneous and neo-atherosclerosis. The presence of microvessels and peri-strut low intensity area (PSLIA) was determined in all ISR. Neoatherosclerosis was identified by lipid, calcium and thin-cap fibro-atheroma (TCFA) like lesions. We compared the two DES generations at both early ( 1 year) follow-ups.In second generation DES a heterogeneous pattern was prevalent both before and after 1 year (57.1% and 58.6% respectively). Neo-atherosclerosis was more common in the early period in first generation DES (19.4% vs 11.7%, p < 0.01), but after one year was more prevalent in second generation DES (7.0% vs 19.3%, p < 0.01). Similar prevalence of TCFAs was observed in both groups in all comparisons. CONCLUSIONS: When ISR restenosis occurs in second generation DES, the current data suggest a different time course and different morphological characteristics from first generation. Future prospective studies should evaluate the relationship between ISR morphology, time course and clinical events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NIHR Biomedical Research Unit, Royal Brompton Hospital & Harefield NHS Foundation Trust, London, UK.
- Department of Clinical and Experimental Medicine, University of Eastern Piedmont, Novara, Italy.
- National Heart and Lung Institute, Imperial College London, London, UK.
Zitieren
APA
Kilickesmez, K., Dall'Ara, G., Rama-Merchan, J. C., Ghione, M., Mattesini, A., Vinues, C. M., Konstantinidis, N., Pighi, M., Estevez-Loureiro, R., Zivelonghi, C., Lindsay, A. C., Secco, G. G., Foin, N., De Silva, R., & Di Mario, C. (2014). Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents. IJC Heart & Vessels, 3, 68-74. https://doi.org/10.1016/j.ijchv.2014.03.003
Vancouver
Kilickesmez K, Dall'Ara G, Rama-Merchan JC, Ghione M, Mattesini A, Vinues CM, et al. Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents. IJC Heart & Vessels. 2014;3:68-74. doi:10.1016/j.ijchv.2014.03.003
BibTeX
@article{Kilickesmez2014,
author = {Kilickesmez, Kadriye and Dall'Ara, Gianni and Rama-Merchan, Juan Carlos and Ghione, Matteo and Mattesini, Alessio and Vinues, Carlos Moreno and Konstantinidis, Nikolaos and Pighi, Michele and Estevez-Loureiro, Rodrigo and Zivelonghi, Carlo and Lindsay, Alistair C and Secco, Gioel G and Foin, Nicolas and De Silva, Ranil and Di Mario, Carlo},
title = {Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents},
journal = {IJC Heart & Vessels},
year = {2014},
volume = {3},
pages = {68--74},
doi = {10.1016/j.ijchv.2014.03.003}
}
EUVIMED